Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharmacyclics' CEO Discusses Q2 2013 Results - Earnings Call Transcript
Seeking Alpha
Friday, February 15, 2013 - 10:43am
tags:
earnings, Pharmacyclics
Merck's Dynamic Duo
Motley Fool
Friday, February 15, 2013 - 10:42am
tags:
Merck, Januvia, Janumet, diabetes
Johnson & Johnson recalls thousands of hip implants, in other countries, for high failure rate
Yahoo/AP
Friday, February 15, 2013 - 10:40am
tags:
recalls, hip implants, DePuy, JNJ
AVEO: Final Overall Survival Results From The TIVO­1 Study
Seeking Alpha
Thursday, February 14, 2013 - 11:18am
tags:
Aveo Pharmaceutical, tivozanib, renal cell carcinoma
ImmunoGen, Surprisingly Quiet Ahead Of FDA Decision
Seeking Alpha
Thursday, February 14, 2013 - 11:17am
tags:
Immunogen, FDA, trastuzumab, Roche
Regeneron profit beats estimates on rising Eylea sales
Reuters
Thursday, February 14, 2013 - 11:15am
tags:
earnings, Regeneron
Discovery Laboratories: Innovative Financing Is A Catalyst To Buy The Stock
Seeking Alpha
Thursday, February 14, 2013 - 11:15am
tags:
Discovery Labs, Surfaxin
Did DaVita Admit Fraud In Suing A Whistleblower?
Pharmalot
Thursday, February 14, 2013 - 10:48am
tags:
DaVita, whistleblower lawsuits
Lilly Threatens To Leave Canada Over Patent Rulings
Pharmalot
Thursday, February 14, 2013 - 10:45am
tags:
Eli Lilly, Canada, patents
Cardinal Health Agrees to Buy AssuraMed for $2.07 Billion
Bloomberg
Thursday, February 14, 2013 - 10:38am
tags:
AssuraMed, Cardinal Health, M&A
Teva Announces FDA Approval of Generic Adderall XR®
Yahoo
Thursday, February 14, 2013 - 10:35am
tags:
FDA, generics, Teva, Adderall ZR, Shire, ADHD
Dr. Reddy's Q3 & 9 Months FY13 Financial Results
Yahoo
Thursday, February 14, 2013 - 10:34am
tags:
earnings, Dr Reddy's
DEALTALK-Drugmakers weigh carve-outs as Abbott, Pfizer set pace
Reuters
Thursday, February 14, 2013 - 10:33am
tags:
Pfizer, Abbott Labs
J&J Feared Metal Backlash Would Hurt Hip Sales, Jury Told
Bloomberg
Thursday, February 14, 2013 - 10:30am
tags:
JNJ, hip implants
3 Events Biotech Investors Need to Watch in 2013
Motley Fool
Thursday, February 14, 2013 - 10:28am
tags:
Vical, Allovectin, metastatic melanoma, Merrimack Pharmaceuticals, MM-398, pancreatic cancer, Afrezza, diabetes, MannKind
FDA Safety Regs Faulted for Lax Oversight
Forbes
Thursday, February 14, 2013 - 10:26am
tags:
FDA
Amarin's Tough Road Ahead
Seeking Alpha
Thursday, February 14, 2013 - 10:25am
tags:
Vascepa, Amarin
Is the Pharma Industry Facing Pharmageddon?
Motley Fool
Thursday, February 14, 2013 - 10:21am
tags:
pharma industry
Qiagen and Lilly expand diagnostic partnership
Yahoo/AP
Thursday, February 14, 2013 - 10:19am
tags:
Eli Lilly, Qiagen, diagnostics
Obama Medicare rebate plan could hurt drug companies
Reuters
Thursday, February 14, 2013 - 10:19am
tags:
Medicare, rebates

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.